Telehealth Provider Organization Antidote Health Raises $22 Million

Antidote Health completed a $22 million Series A funding round. The company provides telehealth services accessible to 60% of the United States population. It plans to use the funds to support research and development of advanced artificial intelligence (AI) screening and clinical decision support system capabilities for chronic conditions and primary care services. It also seeks to accelerate its growth in the United States.

The funding round was led by third-time investor iAngels, as well as by Group 11, and Flint Capital. Shelly Hod Moyal, founding partner at iAngels said “Antidote Health's team of medical and tech experts . . .